Cargando…
The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O‐, S,O‐, and N,N‐Chelate Effects
The synthesis, characterization and biological activity of molybdenum(IV) complexes containing Trofimenko's scorpionato ligand, hydrotris(3‐isopropylpyrazolyl)borate (Tp(iPr)), in addition to varying biologically active as well as other conventional ligands is described. Ligands employed includ...
Autores principales: | Berasaluce, Iker, Cseh, Klaudia, Roller, Alexander, Hejl, Michaela, Heffeter, Petra, Berger, Walter, Jakupec, Michael A., Kandioller, Wolfgang, Malarek, Michael S., Keppler, Bernhard K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064950/ https://www.ncbi.nlm.nih.gov/pubmed/31560142 http://dx.doi.org/10.1002/chem.201903605 |
Ejemplares similares
-
Anticancer Tungstenocenes with a Diverse Set of (O,O–), (O,S–) and (O,N–) Chelates—A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models
por: Cseh, Klaudia, et al.
Publicado: (2023) -
Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles
por: Mokesch, Stephan, et al.
Publicado: (2020) -
Tris-(2-pyridyl)-pyrazolyl Borate Zinc(II) Complexes: Synthesis, DNA/Protein Binding and In Vitro Cytotoxicity Studies
por: Narwane, Manmath, et al.
Publicado: (2021) -
Neodymium(III) molybdenum(VI) borate, NdBO(2)MoO(4)
por: Held, Peter, et al.
Publicado: (2011) -
Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group
por: Mokesch, Stephan, et al.
Publicado: (2019)